Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 436 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Ability of Deep Learning to Accurately Diagnose Frequent STS Subtypes from... August 26, 2021 “That is what I dream”: India’s journey to rolling out the... November 17, 2021 Synchronized Swimmer Learns She Has Breast Cancer After Teammate Kicks Her... March 4, 2020 癌症可以在家族成员中被遗传吗？ October 13, 2020 Load more HOT NEWS Child With Cancer Becomes Honorary First Responder With Two FDA Approvals, Prostate Cancer Treatment Enters the PARP Era African American Men More Likely to Die from Low-Grade Prostate Cancer Woman Who Died For 27 Minutes Shares Haunting Message When Revived
